Overview of Guarantee Situation - The company approved a guarantee for its wholly-owned subsidiary, Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd., to apply for a comprehensive credit limit of RMB 1.368 billion from relevant banks [3] - The guarantee is within the approved limit, and no further approval procedures are required [5] Guarantee Progress - A maximum guarantee contract was signed with Shanghai Pudong Development Bank Taiyuan Branch, providing a joint liability guarantee for the subsidiary with a principal balance of up to RMB 30 million [4] Basic Information of the Guaranteed Party - Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. has a registered capital of RMB 31.3 million and was established on November 27, 2009 [6] - The company operates in various sectors, including drug retail, medical device sales, and food sales [6][7] - The subsidiary is fully owned by the company, holding 100% of its shares [7] Financial Indicators - Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. has a good credit status and is not listed as a dishonest executor [8] Main Content of the Guarantee Agreement - The creditor is Shanghai Pudong Development Bank Taiyuan Branch, the guarantor is the company, and the debtor is Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. [9] - The guarantee covers the principal debt and related interests, penalties, and other costs incurred [9][10] Necessity and Reasonableness of the Guarantee - The guarantee is necessary for the subsidiary's daily operational needs and is expected to positively impact the company's development and efficiency [12] - The subsidiary has the ability to repay its debts, and the risks associated with the guarantee are controllable [12] Cumulative External Guarantee Amount - After this guarantee, the total guarantee amount for the company and its subsidiaries is RMB 1.34227 billion, with a total balance of RMB 843.7792 million, accounting for 11.03% of the company's audited net assets for 2024 [13]
一心堂药业集团股份有限公司 关于全资子公司山西鸿翔一心堂药业有限公司 向银行申请授信额度提供担保的进展公告